公司新闻 - 亚科因（Abbkine）—服务于细胞和蛋白研究全球用户

公司新闻 - 亚科因（Abbkine）—服务于细胞和蛋白研究全球用户

首页
技术中心
产品文献

或

货号	产品名称	文献标题	IF	杂志名称
PRP1119	重组小鼠白介素-1β（IL-1β）	Calycosin ameliorates osteoarthritis by regulating the imbalance between chondrocyte synthesis and catabolism.	3	BMC Complementary Medicine and Therapies
PRP2117	重组小鼠白介素-4，His-标签（无动物源）（IL-4）	Nrf2 Deficiency Exacerbated CLP-Induced Pulmonary Injury and Inflammation through Autophagy- and NF-κB/PPARγ-Mediated Macrophage Polarization	8	Cells
PRP2117	重组小鼠白介素-4，His-标签（无动物源）（IL-4）	Single-injection COVID-19 subunit vaccine elicits potent immune responses	11	Acta Biomaterialia
PRP2117	重组小鼠白介素-4，His-标签（无动物源）（IL-4）	Myricetin alleviates DNCB-induced atopic dermatitis by modulating macrophage M1/M2 polarization	5	Apoptosis
PRP2117	重组小鼠白介素-4，His-标签（无动物源）（IL-4）	Polypeptide sono-adjuvant for ultrasound-activatable regulation of innate immunity and cancer vaccination therapy	16	Journal of Cellular and Molecular Medicine
PRP1028	重组人TNF相关的凋亡诱导配体（TRAIL）	TMB Signature-Related RCAN2 Promotes Apoptosis by Upregulating EHF/DR5 Pathway in Hepatocellular Carcinoma.	3	Frontiers in Bioscience-Landmark
PRP100108	重组人白介素-13（IL-13）	Integrative Analysis Reveals a miRNA-mRNA Regulatory Network and Potential Causative Agents in the Asthmatic Airway Epithelium	4	Journal of Asthma
PRP100108	重组人白介素-13（IL-13）	The TL1A-DR3 Axis in Asthma: Membrane-Bound and Secreted TL1A Co-Determined the Development of Airway Remodeling	4	Allergy Asthma Immunol Res
PRP100159	重组人表皮生长因子（EGF）	He, Hua, et al. "GINS2 regulates temozolomide chemosensitivity via the EGR1/ECT2 axis in gliomas."Cell Death & Disease15.3 (2024): 205.	8	Cell Death & Disease
PRP100190	重组人转化生长因子-β1（TGF-β1）	DNMT1 mediates the disturbed flow-induced endothelial to mesenchymal transition through disrupting β-alanine and carnosine homeostasis	13	Int J Clin Exp Pathol

首页上一页 1 2 3 4 5 6 下一页尾页

赋能细胞研究与治疗 Enabling cell research and therapy

联系我们

全国服务热线： 400-6800-830

订购邮箱： service@abbkine.com

联系地址：武汉光谷生物医药加速器17号楼1号房2-3层

友情链接：

Copyright ©Abbkine Scientific Co., Ltd- 鄂ICP备10204150号-5

意见反馈

 在线咨询

扫码关注

微信公众号

返回顶部